Weak pound boosts GSK first quarter revenue but company warns of generic competition
Drug-making giant beats forecast after reporting 19% year-on-year increase in Q1 revenue.
Rise of the machine: How automation is redefining work and real estate
Landmark properties are already maximising opportunities afforded by intelligent automation.
GlaxoSmithKline warns of generic competition for key US asthma drug
As Glaxo boss Sir Andrew Witty perpares to hand over the reins he warns of competition for its key Advair treatment.
Boost for UK economy as drug giant makes major investment in Oxford
Danish firm Novo Nordisk will invest £115m over the next decade to develop a research centre in Oxford.
Davos 2017: GSK chief says weak pound has been a boost and wants more transparency over drug pricing
GlaxoSmithKline has benefitted from pound's sharp decline but new EU regulations could be a concern.
Smart buildings and workplace-as-a-service will disrupt the commercial real estate sector
From millennial workers to IT-savvy finance directors, everyone is demanding more from their buildings.
GlaxoSmithKline's new asthma drug earns UK approval after price cut
While Nucala has a list price of £840 per dose, the price it will be sold to the NHS is confidential.
GlaxoSmithKline tops access to medicine list for fifth time
World's top drug makers continuing to expand access to medicine in developing countries, report finds.
GlaxoSmithKline sees profits soar on weakness of the pound
A weaker pound and growth at its vaccines unit lifts profits at the drug giant.
UK stands eighth in corporate R&D spending, Global Innovation 1000 study says
AstraZeneca, GSK, Rolls-Royce, BP and Unilever among top 10 UK R&D spenders during the last fiscal year.
GlaxoSmithKline seeks FDA approval for shingles vaccine
According to analysts, Shingrix has the potential to earn $1bn annually.
GlaxoSmithKline's new boss: Who is Emma Walmsley?
Most powerful chief executive in the UK will have to come up with new drugs.
Emma Walmsley becomes CEO of pharmaceutical giant GlaxoSmithKline
The drugs giant names new chief executive as investors hope she will kick-start a new period of growth.
UK pharmaceutical firms have weathered Brexit storms but face long-term challenges
Sector is seen as a safe haven but it faces increasing regulatory costs in the future.
GlaxoSmithKline and Alphabet's Verily partner for development of bioelectronic medicines
The new company will enable research, development and commercialisation of bioelectronic medicines.
Glaxo posts jump in profits on new drug sales
GlaxoSmithKline said development work on its new drug pipeline is starting to pay off
GSK to invest £275m in Britain in major boost to UK economy
FTSE 100 drug maker will invest across three different UK sites and create new jobs
Brexit fallout: Rolls-Royce, GlaxoSmithKline and Experian are big winners from a weak pound
Companies that export from the UK to Europe are benefiting from a falling pound.
FTSE Moves: Top flight shares edge up after Bank of England eases capital buffers
Bank of England governor Mark Carney lifts markets after easing capital requirements for lenders.
GlaxoSmithKline gel developed from a mouthwash could save thousands of babies
The antiseptic gel called Umbipro was developed in partnership with the charity Save the Children.
GlaxoSmithKline to share knowledge on cancer drugs to benefit poorer countries
The Brentford headquartered company to allow competitors access to its patent pool.
GlaxoSmithKline CEO Sir Andrew Witty to step down earlier than expected in 2017
GSK chief executive will step down in March next year after bowing to pressure from shareholders.
GlaxoSmithKline hit by £37m fine from CMA for breaching law on anticompetitive agreements
CMA sanctions £37m fine after GSK paid £50m to stifle competition on one of its drugs between 2001 and 2004.
Biggest British multinationals paid little or no UK corporation tax in 2014
A Sunday Times investigation found that the likes of the likes of Shell, Lloyds and Vodafone paid no taxes.
GlaxoSmithKline 300th anniversary: From small east London pharmacy to multinational giant
In 300 years, GSK has grown from a small pharmacy to a multinational corporation.
Study 329: Antidepressant trial's upended results show need for sharing all data
BMJ paper re-examines 'landmark' study of antidepressant use in teens
China explosion: Major disruption expected at Tianjin port
BHP Billiton, Volkswagen, Toyota and AP Moller-Maersk among international companies affected.
Malaria vaccine: Mosquirix gets positive appraisal from EU regulator ahead of WHO testing
RTS,S vaccine developed by GlaxoSmithKline gets positive EMA review and next goes to WHO for tests
GSK investigator Peter Humphrey's American wife released early from China jail
Both Humphrey and his wife Yu Yingzeng were released on the same day, says family friend.
British investigator linked to GSK Peter Humphrey released early from Chinese jail
Humphrey's two and a half year jail sentence cut by seven months.